Skip to content

NeoGenomics NEO Total Operating Expenses

Total Operating Expenses at other companies

Immunome logo
ImmunomeIMNM
$59.33M+24.7%
CareDx logo
CareDxCDNA
$116.5M+18.8%
TEC
Bio-TechneTECH
$132.79M-24.5%
BillionToOne, Inc.
 logo
BillionToOne, Inc. BLLN
$61.26M+52.1%
Veracyte logo
VeracyteVCYT
$28.56M+16.0%
Azenta logo
AzentaAZTA
$227.83M+181%

Other financials

Income statement

See full
Revenue$186.7M+11.1%
Gross profit$80.9M+10.4%
Operating income-$18.2M+34.4%
Net income-$17.1M+34.0%
EPS (diluted)-$0.13+35.0%

Balance sheet

See full
Cash & equivalents$146.1M-57.8%
Total debt$66.3M+5.3%
Total equity$828.8M-6.7%
Total assets$1.3B-15.9%

Cash flow

See full
Operating cash flow-$8.1M+67.9%
CapEx$5.0M+11.1%
Free cash flow-$13.1M+56.0%

Valuation

See full
Market cap$1.68B-21.0%
Enterprise value$1.6B-5.6%
P/S2.3×-0.9×

Profitability

See full
Gross margin43.2%-1.1pp
Operating margin-14.2%+1.1pp
Net margin-13.3%+2.4pp
FCF margin-4.9%

Returns & leverage

See full
Return on equity-11.6%+6.2pp
Debt / equity0.1×0.0×
Current ratio4.4×+2.4×

Where this comes from

Reported directly by NeoGenomics in its filing.

Tagged under the XBRL concept us-gaap:OperatingExpenses.

The official record: NeoGenomics’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about NeoGenomics's total operating expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is NeoGenomics's total operating expenses?
NeoGenomics (NEO) reported total operating expenses of $99.11M in Q1 2026.
How has NeoGenomics's total operating expenses changed year-over-year?
NeoGenomics's total operating expenses decreased by 1.9% year-over-year, from $101.07M to $99.11M.
What is the long-term trend for NeoGenomics's total operating expenses?
Over 4 years (2021 to 2025), NeoGenomics's total operating expenses has grown at a 8.9% compound annual growth rate (CAGR), from $305.81M to $430.17M.
What does total operating expenses mean?
The sum of all operating costs including COGS, SG&A, R&D, D&A, and other operating charges. Revenue minus total operating expenses equals operating income.